International Journal of Radiation Oncology * Biology * Physics
Volume 80, Issue 5 , Pages 1423-1429 , 1 August 2011

Marginal Misses After Postoperative Intensity-Modulated Radiotherapy for Head and Neck Cancer

This study was presented in part at the 2008 Annual meeting of the American Radium Society, May 1-7 2008 Dana Point, California.

  • Allen M. Chen, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California
    • Corresponding Author InformationReprint requests to: Allen M. Chen, M.D., Department of Radiation Oncology, University of California Davis Cancer Center, 4501 X Street, Suite G0140, Sacramento, CA 95817. Tel: (916) 734-8051; Fax (916) 703-5069
    • ,
  • D. Gregory Farwell, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California
    • ,
  • Quang Luu, M.D.

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, University of California Davis School of Medicine, Sacramento, California
    • ,
  • Leon M. Chen, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California
    • ,
  • Srinivasan Vijayakumar, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California
    • ,
  • James A. Purdy, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California

Received 28 September 2009 ,Revised 30 March 2010 ,Accepted 3 April 2010.

References 

  1. Mendenhall WM, Mancuso AA. Radiotherapy for head and neck cancer: Is the "next level" down?. Int J Radiat Oncol Biol Phys. 2009;73:645–646
  2. Harari PM. Beware the swing and a miss: Baseball precautions for conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:657–659
  3. Lee WR. Technology assessment: Vigilance required. Int J Radiat Oncol Biol Phys. 2008;70:652–653
  4. Gregoire V, Eisbruch A, Hamoir M, et al. Proposal for the delineation of the nodal CTV in the node-positive and post-operative neck. Radiother Oncol. 2006;15–20
  5. Apisarnthanarax S, Elliott DD, El Naggar AK, et al. Determining optimal clinical target volume in head and neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys. 2002;53:1174–1184
  6. Poon I, Fischbein N, Lee N, et al. A population-based atlas and clinical target volume for the head and neck lymph nodes. Int J Radiat Oncol Biol Phys. 2004;59:1301–1311
  7. Rasch C, Steenbakkers R, van Herk M. Target definition in prostate, head, and neck. Semin Radiat Oncol. 2005;15:136–145
  8. Greene FL, Page DL, Fleming ID, et al. AJCC Staging Manual (ed 6). New York, NY: Springer-Verlag; 2002;
  9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:547–581
  10. Dawson LA, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46:1117–1126
  11. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head and neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59:28–42
  12. Chao KSC, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312–321
  13. Logue JP, Sharrock CL, Cowan RA, et al. Clinical variability of target volume description in conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 1998;41:929–931
  14. Nowak P, Wijers OB, Lagerwaard FJ, et al. A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys. 1999;45:33–39
  15. Som PM, Curtin HD, Mancuso AA. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol. 2000;174:837–845
  16. Wijers OB, Levendag PC, Tan T, et al. A simplified CT-based definition of the lymph node levels in the node negative neck. Radiother Oncol. 1999;52:35–42
  17. Levendag P, Braaksma M, Coche E, et al. Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American academy of otolaryngology-head and neck surgery. Int J Radiat Oncol Biol Phys. 2004;58:113–123
  18. DAHANCA, EORTC, GORTEC, NCIC and RTOG endorsed consensus guidelines for the delineation of the CTV in the N0 neck of patients with head and neck squamous cell carcinoma. http://www.rtog.org/atlases/hnatlas/main.html. Accessed December 1, 2008.
  19. Palazzi M, Fossa-Jereczeck BA, Soatti C. CT-based delineation of lymph node levels in the neck: Can we optimize the consensus?. Radiother Oncol. 2004;73:383–386
  20. Eisbruch A, Gregoire V. Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. Semin Radiat Oncol. 2009;19:43–52
  21. Cannon DM, Lee NY. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;70:660–665
  22. Schoenfeld GO, Amdur RJ, Morris CG, et al. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;71:377–385
  23. Lee N, Xia P, Fischbein NJ, et al. Intensity-modulated radiation therapy for head and neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57:49–60
  24. Gomez DR, Zhung JE, Gomez J, et al. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys. 2009;73:1096–1103
  25. Lee N, Chuang C, Quivey J, et al. Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2002;53:630–637
  26. Daly ME, Lierskovsky Y, Pawlicki T, et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity-modulated radiotherapy of head and neck squamous cell carcinoma. Head Neck. 2007;29:211–220
  27. Rosenthal DI, Chambers MS, Fuller CD, et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;72:747–755
  28. Purdy JA. Dose to normal tissues outside the radiation therapy patient's treated volume: A review of different radiation therapy techniques. Health Phys. 2008;95:666–676
  29. Khuntia D, Harris J, Bentzen SM, et al. Increased oral mucositis after IMRT versus non-IMRT when combined with cetuximab and cisplatin or docetaxel for head and neck cancer: preliminary results of RTOG 0234. Int J Radiat Oncol Biol Phys. 2008;72:S33
  30. Yao M, Chang K, Funk GF, et al. Intensity-modulated radiotherapy for head and neck squamous cell carcinoma: the University of Iowa experience. Int J Radiat Oncol Biol Phys. 2005;63:410-421
  31. Studer G, Zwahlen RA, Graetz KW, et al. IMRT in oral cavity cancer. Radiat Oncol. 2007;2:16–23

 Conflict of interest: none.

PII: S0360-3016(10)00529-8

doi: 10.1016/j.ijrobp.2010.04.011

International Journal of Radiation Oncology * Biology * Physics
Volume 80, Issue 5 , Pages 1423-1429 , 1 August 2011

Article Tools

* Image Usage & Resolution